[go: up one dir, main page]

WO2003065979A3 - Procedes de diagnostic, de controle et de traitement de la sterilite - Google Patents

Procedes de diagnostic, de controle et de traitement de la sterilite Download PDF

Info

Publication number
WO2003065979A3
WO2003065979A3 PCT/US2002/038629 US0238629W WO03065979A3 WO 2003065979 A3 WO2003065979 A3 WO 2003065979A3 US 0238629 W US0238629 W US 0238629W WO 03065979 A3 WO03065979 A3 WO 03065979A3
Authority
WO
WIPO (PCT)
Prior art keywords
fertility
diagnosis
monitoring
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/038629
Other languages
English (en)
Other versions
WO2003065979A2 (fr
Inventor
Yousef Ai-Abed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Feinstein Institutes for Medical Research
Original Assignee
North Shore Long Island Jewish Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Shore Long Island Jewish Research Institute filed Critical North Shore Long Island Jewish Research Institute
Priority to AU2002365941A priority Critical patent/AU2002365941A1/en
Publication of WO2003065979A2 publication Critical patent/WO2003065979A2/fr
Publication of WO2003065979A3 publication Critical patent/WO2003065979A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/533Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/US2002/038629 2001-12-05 2002-12-05 Procedes de diagnostic, de controle et de traitement de la sterilite Ceased WO2003065979A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365941A AU2002365941A1 (en) 2001-12-05 2002-12-05 Methods of diagnosis, monitoring and treatment of fertility

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35575501P 2001-12-05 2001-12-05
US60/355,755 2001-12-05

Publications (2)

Publication Number Publication Date
WO2003065979A2 WO2003065979A2 (fr) 2003-08-14
WO2003065979A3 true WO2003065979A3 (fr) 2004-02-12

Family

ID=27734557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038629 Ceased WO2003065979A2 (fr) 2001-12-05 2002-12-05 Procedes de diagnostic, de controle et de traitement de la sterilite

Country Status (2)

Country Link
AU (1) AU2002365941A1 (fr)
WO (1) WO2003065979A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2006102191A1 (fr) 2005-03-24 2006-09-28 Avanir Pharmaceuticals Derives de thienopyridinone utilises en tant qu'inhibiteurs du facteur d'inhibition de la migration des macrophages
WO2007044622A1 (fr) * 2005-10-07 2007-04-19 Yale University Utilisation de mif et d'agonistes de la voie mif
CA2765855C (fr) * 2009-06-17 2015-02-03 Hiroshima University Solution diluante de sperme et procede d'insemination artificielle l'utilisant
US20150359763A1 (en) * 2013-01-30 2015-12-17 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada Use of 3-bromopyruvate as a contraceptive

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420188B1 (en) * 1996-02-16 2002-07-16 The Picower Institute For Medical Research Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
US6492428B1 (en) * 2000-07-26 2002-12-10 The Picower Institute For Medical Research Compounds having MIF antagonist activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420188B1 (en) * 1996-02-16 2002-07-16 The Picower Institute For Medical Research Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
US6492428B1 (en) * 2000-07-26 2002-12-10 The Picower Institute For Medical Research Compounds having MIF antagonist activity

Also Published As

Publication number Publication date
AU2002365941A1 (en) 2003-09-02
WO2003065979A2 (fr) 2003-08-14
AU2002365941A8 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
AUPR733901A0 (en) Method and means of physiological monitoring
WO2002086502A8 (fr) Procedes de diagnostic et de traitement de maladies des os
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
AU2002247004A1 (en) Methods of diagnosis and treatment of osteoporosis
AU2002346783A1 (en) Composite nonwoven, its use and method of manufacture
AU2002329570A1 (en) Method of monitoring neuroprotective treatment
AU6630101A (en) Chest piece for stethoscopes, and methods of utilizing stethoscopes for monitoring the physiological conditons of patient
AU2002348297A1 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
AU2002312315A1 (en) Microfabricated surgical devices and methods of making the same
AU2002321349A1 (en) Method for modification of starch, starch and its use
AU2002219137A1 (en) Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
AU2002324072A1 (en) Method, device and system for measuring and transmitting functional values of the body
AU2001236234A1 (en) Patient monitoring devices and methods
AU2002365941A1 (en) Methods of diagnosis, monitoring and treatment of fertility
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AU2002246049A1 (en) Water-absorbing agent, method for the production thereof and use of the same
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002240745A1 (en) Diagnosis and treatment of blood disorders
AU2002100671A4 (en) Method and means of physiological monitoring
AU2002232563A1 (en) Compounds for therapy and diagnosis and methods for using same
AU2003237143A1 (en) Diagnosis and treatment of glaucoma
WO2003011130A8 (fr) Methode de detection du cancer par agent d'accentuation thermique et surveillance thermique non infractive
AU2003905953A0 (en) Methods of treatment, prophylaxis and diagnosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP